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ABSTRACT 
 
Otitis media (OM) is the most common illness in children in the United States. 
Three-fourths of children under the age of three have OM at least once. Children with 
chronic OM, including OM with effusion and recurrent OM, will often have conductive 
hearing loss and communication difficulties, and will need surgical treatment. Recent 
clinical studies state that almost all chronic OM cases are accompanied by a bacterial 
biofilm behind the tympanic membrane (eardrum). Biofilms are typically very thin, 
making them difficult to be recognized using a regular otoscope. However, low-
coherence interferometry (LCI) is capable of detecting and quantifying this 
microstructure. The goal of this research was to design a portable system integrating LCI 
with a standard video otoscope to detect the presence of biofilms and provide quantitative 
information about the middle ear to assist physicians in diagnosing middle ear infections. 
In the future, it is expected such quantitative information will direct and monitor 
treatment protocols. The system uses a super-luminescent diode centered at 940 nm with 
a bandwidth of 60 nm and the axial resolution of ~ 4.5 µm in tissue. Axial scans are 
acquired in vivo at the rate of 2 kHz and using a custom automated algorithm classified 
according to microstructural features to provide statistical determination for OM status. 
Preliminary results are described in a rat OM model and in humans. 
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CHAPTER 1 - INTRODUCTION 
 
1.1 OTITIS MEDIA 
Otitis media (OM) is a middle ear infection occurring between the tympanic 
membrane (TM) and the inner ear. Ear infection occurs when bacteria get into the middle 
ear, reproduce, and cause fluid that is unable to drain because of swelling and 
inflammation. Young children frequently acquire ear infection after colds, a food allergy, 
or respiratory infection. Middle ear infections occur in about 75% of children by the age 
of three and are the most common cause of visits to physicians of children at this age [1].  
The middle ear is the portion that includes the tympanic membrane (TM), or 
eardrum, the ossicular bones, and the middle ear cavity, which connects to the upper 
throat (nasopharynx) by the Eustachian tube (Figure 1). In young children, the Eustachian 
tube lies at an angle of 10
o 
compared to 45
o
 in adults. This allows the bacteria from an  
upper throat infection more easily to get to the ear cavity in children. Smaller-diameter 
Eustachian tubes in children also prevent the drainage of fluid in the ear cavity. 
Furthermore, more likely contact with other sick children and poor hygiene habits 
increase the probability of an ear infection. This explains why ear infections occur much 
more frequently in young children. 
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Figure 1 Diagram of the middle ear (from [2]). 
Ear infections are classified based on symptoms, duration, and physical diagnosis. 
The most frequent type is acute otitis media (AOM) which is a rapid infection with one or 
more symptoms such as otalgia, fever, and irritability. In this case, the physician often 
finds an abnormally appearing tympanic membrane that has bulging, opacity, effusion, 
and decreased mobility during pneumatic otoscopy. Example images of a normal ear and 
one with AOM are shown in Figure 2. The normal tympanic membrane (Figure 2 (left)) 
appears translucent to slightly opaque, while the ear with AOM (Figure 2 (right)) appears 
red and inflamed. Otitis media can be a recurrent disease, and more than one-third of 
children under seven years of age have at least six recurrent episodes of AOM. Middle 
ear effusions often occur after AOM, frequently followed by chronic infections. Even 
though chronic infections can cause long-term or permanent damage to the ear, there may 
be less-severe signs or symptoms of infection than AOM that may cause the infection to 
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persist unnoticed and untreated for a long time. Chronic OM often causes tissue 
hardening and pus-like drainage in the inner ear and damage to the mastoid bone.  
 
 
Figure 2 Example images of tympanic membranes in a normal ear (left) and one 
with AOM (right) (from [3]). 
Therefore, chronic OM often causes hearing loss and communication impairment, 
especially in small children who are in the process of learning to speak [4-5]. Hearing 
loss, especially to soft sounds, is also one of the two important symptoms of chronic OM, 
in addition to an obvious late-stage tear or hole in the TM. 
AOM may clear in two weeks without treatment or may need to be treated with 
antibiotics. Antibiotic prescriptions for ear infections are made for about 50% of all 
children younger than 3 years of age and suffering from OM. However, in the case of 
chronic OM, antibiotics may not always be helpful, and a surgical treatment of placing a 
tympanostomy tube in the TM is strongly recommended. The tympanostomy tube will 
help drain middle ear fluid out to the external ear canal. This surgery is also the most 
common surgical procedure for young children [4].  
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1.2 CHRONIC OTITIS MEDIA AND BACTERIAL BIOFILMS 
Because of the widespread prevalence and possible complications of middle ear 
infections, it is important to diagnose middle ear infections and determine their status in 
order to determine the most effective treatment.  Overuse and misuse of antibiotics in 
OM has contributed to resistant bacteria, further complicating the management of this 
disease [6]. The diagnostic challenge is the difficulty in discriminating acute OM from 
chronic OM and tracking the antibiotic treatment response using a standard otoscope. 
This challenge exists even for physicians experienced in investigating the various colors 
and shapes of the tympanic membrane, and the characterization of fluids or effusions.  
Currently, chronic OM is diagnosed by several methods. Standard otoscopy is 
used most frequently; however, the signs of OM are not always revealed with this 
method. The accuracy of standard otoscopy is limited to a sensitivity and specificity of 
74% and 60%, respectively. Other currently available diagnostic methods, such as 
pneumatic otoscopy and tympanometry, can yield slightly higher sensitivities and 
specificities (70% to 90%) in ideal conditions compared to standard otoscopy. However, 
both pneumatic otoscopy and tympanometry still have technical challenges in obtaining a 
good seal within the ear canal, and accurate measurements not only require a proper size 
of ear tip but also depend heavily on patient cooperation. Other factors like cerumen or 
pressure level also have an effect on the measurement accuracy. Therefore, a combination 
of the three methods, otoscopy, pneumatic otoscopy, and tympanometry, are now 
recommended for the diagnosis of chronic OM [7–8]. Furthermore, these methods can be 
used to detect the presence of an effusion in chronic OM, but are limited to qualitatively 
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tracking changes during treatment processes. 
Recent clinical studies have shown that there is a one-to-one correspondence 
between chronic OM and the presence of bacterial biofilms behind the tympanic 
membrane. Mucosal biofilms were visualized by confocal laser scanning microscopy in 
46 out of 52 middle ear mucosal specimens of 26 patients undergoing tube placement for 
chronic OM [9]. There are also observations of biofilm formation in induced chronic OM 
in animal models like the chinchilla and monkey [10]. It has been shown that the 
pathogenic bacteria Pseudomonas aeruginosa, which exists in all infected middle ear 
cultures, forms a biofilm in the middle ear.  
In general, biofilms are the habitat for microorganisms (e.g. bacteria, fungi, and 
viruses) that grow collectively in adhesive self-forming biopolymers. Within biofilms, 
microbes are protected from harsh environments, including antibiotic or biocide 
treatments. Biofilm structures were recently found to have heterogeneous features such as  
cell distribution, aggregation, voids, and fluid channels. The presence of a bacterial 
biofilm is now considered the cause and reservoir of the disease and explains why 
antibiotics have not been optimally effective for chronic OM [11−13].  
 
1.3 LOW-COHERENCE INTERFEROMETRY AND OPTICAL COHERENCE 
TOMOGRAPHY TECHNIQUES FOR IMAGING THE MIDDLE EAR AND 
BIOFILMS 
 
The impact of OM motivates the use of an imaging technique to detect biofilms 
behind the TM in order to distinguish chronic OM and acute OM. Tympanic membranes 
and biofilms are approximately 100 µm thick. These micro-features of the middle ear are, 
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therefore, not suitable for the more traditional medical imaging techniques such as CT, 
MRI, and ultrasound, even with state-of-the-art high-resolution methods.  
Low-coherence interferometry is an optical ranging technique that is capable of 
measuring one-dimensional, depth-resolved tissue structure with a typical resolution of 
several microns. To perform LCI, low-coherence light is generated from a broadband 
optical source and split by a beam splitter or fiber-optic coupler into two beams that are 
sent to sample and reference arms of the interferometer.  The reference arm contains a 
stationary mirror, while the sample arm contains beam-delivery optics directed toward 
the sample.  The interference of the two back-reflected or scattered beams is captured by 
a linear photodetector array and processed by a computer to describe the depth-resolved 
optical scattering properties of the tissue. The broadband, near-infrared light used in LCI 
allows for axial resolutions of up to 2–3 µm and penetration depths of up to 2–3 mm in 
highly-scattering tissues.  The spatial variations in the optical backscattered signal are 
used to describe the microstructures of the tissues. With additional transverse (lateral) 
scanning mechanisms and by assembling adjacent depth scans, optical coherence 
tomography (OCT) images can be generated, which represent cross-sectional images of 
tissue [14-15]. 
Imaging of the middle ear using the LCI/OCT technique has been demonstrated 
by several research groups. In Figure 3(a), all microstructures of the middle ear, such as 
the tympanic membrane, the malleus, the incus, the chodra tympani nerve, and the tendon 
of the tensor tympani muscle, are clearly visualized [16-17]. With high resolution, 
LCI/OCT is also capable of imaging the microstructures of biofilms. Previous research in 
Prof. Stephen Boppart’s group has visualized the growth of biofilms in a tube using OCT 
 7 
images acquired over time. Reconstructed 2-D and 3-D images of a 3-day-old P. 
aeruginosa biofilm grown in a standard capillary flow-cell model are shown in Figure 
3(b). 
 
(a)     (b) 
Figure 3 (a) Ex vivo OCT image of the human middle ear (from [16]) shows the tympanic 
membrane (TM), the chodra tympani nerve (CT), the malleus (M), and the incus (I). (b) 
OCT images shows a 3-day-old biofilm grown in a standard capillary flow-cell model (from 
[18]).   
The use of LCI or OCT for middle ear assessment and imaging offers several 
advantages. First, these techniques have the potential to non-invasively detect and 
quantitatively assess the presence of biofilms behind the TM, while standard otoscopy or 
ultrasound imaging cannot. Second, while both LCI and OCT can provide new useful 
information, LCI is faster and more compact, with fewer requirements for mechanical 
scanning compared to OCT. Small disposable fibers mounted in ear specula can be used 
to perform LCI, instead of complex micro-mechanical scanning systems (MEMs). Even 
though MEM-based scanners would make OCT imaging of the ear possible [19-20], the 
LCI technique is more suitable for portable systems. Finally, the integration of the LCI 
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system with otoscopy enables a simple, low-cost, and non-invasive solution to providing 
new and quantitative information on the middle ear, particularly for detecting, assessing, 
and monitoring the middle ear for biofilms and their role in the treatment of OM. 
 
1.4 CLASSIFICATION ALGORITHM OF LCI DATA FROM MIDDLE EARS 
 
Data acquired from the middle ear by an LCI system (i.e., axial scans) are used to 
quantitatively characterize the middle ear structure and classify OM status. In previous 
research, LCI data have been used to efficiently classify human breast tissue [21-22]. In 
OM classification, acute OM and chronic OM will be classified by the presence or 
absence, respectively of a bacterial biofilm. These biofilms and TM are visualized in LCI 
data by scattering layers. This thesis will present a method to analyze these layers from 
each axial scan using three different parameters: thickness of TM with or without a 
biofilm layer, intensity of optical backscatter, and optical attenuation through these 
structures. The statistical result from this axial scan classification represents the 
probability of a biofilm and provides the physician with a quantitative assessment for OM 
diagnosis. 
 
1.5 GOAL OF THE PROJECT 
 
On the basis of the established correspondence of biofilms with chronic OM [9] 
and the demonstrated capability of imaging the middle ear and cultured biofilms using 
the LCI/OCT technique, the purpose of this project is to design, construct, test, and 
evaluate a system that integrates the LCI technique into a standard video otoscope to 
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assist physicians in determining ear infection status. The video otoscope is used to guide 
the LCI beam to areas of interest on the tympanic membrane and also to record the 
locations of the sampled data. The enhancement of the system can be described by three 
important features: 
• Ability to detect the presence of biofilms behind the eardrum, which therefore can 
help physicians decide whether the middle ear infection is chronic or acute. 
• Providing quantitative information about the middle ear: the thickness and 
movement of the eardrum, and the growth process of bacterial biofilms. 
•  Giving more diagnostic information, such as the presence and characteristics of 
an effusion in the middle ear, when the visual light cannot access it. 
The complete integrated LCI-otoscope has been built to acquire middle ear data 
from a new animal model. This animal model has been developed specifically in Prof. 
Boppart’s laboratory to grow biofilms in the middle ears of rats. The execution of this 
new classification of LCI data from the middle ears of rats demonstrates how biofilms 
and chronic OM can be detected. 
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CHAPTER 2 - BACKGROUND 
 
2.1 LOW-COHERENCE INTERFEROMETRY AND OPTICAL COHERENCE 
TOMOGRAPHY 
 
Low-coherence interferometry (LCI) is an optical ranging technique that is 
capable of measuring one-dimensional, depth-resolved tissue structure with a typical 
resolution of several microns. This technique is sensitive to the optical scattering 
properties of the tissue, sensed from the interference pattern of near-infrared light 
reflected from the tissue and a reference reflection. A diagram of a LCI system is given in 
Figure 4. 
 
Figure 4 Diagram of a LCI system.   
The interferometer in the LCI system splits a broadband light field into two 
fields, sending a reference field to the reference mirror and a sample field to the tissue. 
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The interference of the two backscattering fields is captured by a photodetector. The 
intensity of the interference is 
))(2cos()(2)()(Re 0
* τφτπνττ +++=+++= gIIIItEtEIII srsrsrsrd        (1) 
where Ir and Is are the mean intensities reflecting from reference arm and sample arm, 
respectively, τ is the optical time delay, g(τ) is the temporal coherence function, and ν0 is 
the center frequency of the source spectrum. 
Below in Figure 5 is an example of the interference pattern from the LCI 
system, showing that the central wavelength is 940 nm and the bandwidth is about 70 nm. 
840 860 880 900 920 940 960 980 1000 1020 1040
 
 
Wavelength (nm)
Figure 5 Interference fringes from an LCI system with a 940 nm central wavelength and a 
70 nm bandwidth. 
According to the Wiener-Khinchin theorem, g(τ) is the Fourier transform of the 
power spectral density of the source 
∫
+∞
∞−
== ννντ πντ deSSFTg j2)()}({)(          (2) 
 12 
From Eq.(2), the shape and bandwidth of the light source spectrum will 
determine the temporal coherence function and, therefore, the interference properties. For 
a Gaussian shape spectrum with a center frequency of ν0 and a bandwidth of ∆ν,  
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is the temporal coherence function.  The corresponding coherence length is 
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In the LCI system, lc also represents the axial resolution. From Eq.(5), a broad 
bandwidth spectrum allows for a high axial resolution along a depth scan. Therefore, the 
use of near-infrared light (for optimal imaging depth in highly scattering tissues) with 
broad bandwidth is preferred in LCI to capture microstructures within tissue. For 
example, this system with an optical source of center wavelength 940 nm and bandwidth 
of 70 nm will be able to measure tissue with an axial resolution about 6.5 µm in air, and 
roughly 4.5 µm in tissue.  
With additional transverse (lateral) scanning mechanisms and by assembling 
adjacent depth scans, optical coherence tomography (OCT) images can be generated to 
visualize cross-sectional features of tissues. Examples of LCI and OCT data are shown in 
Figure 6, the OCT image (Figure 6(left)) was from the tympanic membrane of an infected 
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rat and imaged ex vivo. The LCI data (Figure 6(right)) is from a single column in the 
OCT image. 
 
Figure 6 Examples of OCT (left) and LCI (right) data. 
 
2.2 ONE-DIMENSIONAL EDGE DETECTION  
 
An LCI scan is the intensity of backscattering from the tissue along its depth. In 
analyzing the LCI data from middle ears, data from different structures (including the 
TM, the TM with additional structures such as biofilms or effusions, edges of the ear 
canal of the TM, and the malleus) are described by a 1-D signal with different 
thicknesses. The thickness of a structure is defined by its edges. Therefore, detecting 
edges to measure thicknesses of structures from LCI data is considered. The Canny 
method has been widely used as the optimal edge detection algorithm [23-24]. Edges of 
the structures in a 1-D signal are defined as the discontinuities, or rapid changes, in 
intensity. Edges are detected by three main steps:  
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• Reduce the noise effect so that noise is not mistaken for edges 
• Measure the change of intensity 
• Mark edges where the change of intensity has peaks 
Measuring the change in intensity can be implemented by a derivative. However, a 
derivative is a high-pass filter, so it maintains the noise structure more than signal 
structure, which often contains lower frequencies.  Therefore, to reduce the effects of 
noise, a low-pass filter is applied before the derivative. From the Canny method, the 
optimal filter is approximately a Gaussian filter. Hence, the optimal detector is a 
derivative of a Gaussian kernel.  The number of samples of the Gaussian kernel is 
correspondingly chosen to the desired scale to detect the edges. An example of a 
Gaussian kernel and its derivative are shown in Figure 7. The input signal, the 
convolution of the signal with the Gaussian derivative, and its minima and maxima which 
imply the edges, are shown in Figure 8. 
 
Figure 7 Example of a Gaussian kernel and its derivative. 
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Figure 8 Example of 1-D edge detection by the Canny method. 
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CHAPTER 3 - INTEGRATED OTOSCOPE SYSTEM  
 
3.1 HARDWARE 
 
The system is constructed with three main components: (1) the low-coherence 
interferometry core as shown in Figure 1, (2) the LCI probe, and (3) a Welch Allyn video 
otoscope. A laptop computer was used to run custom software to control the system and 
process, analyze, and display both the video otoscope and LCI data. The system is 
compact, portable, and convenient for use in outpatient clinic settings. 
 
3.1.1 LCI core 
 
In the LCI core, a spectral-domain system is used in order to have improved 
signal-to-noise ratio compared to a conventional time-domain LCI system [25]. The light 
source of the system is a super-luminescent diode (SLD) (Pilot-2, Superlum, Moscow, 
Russia). This SLD has a wavelength of 940 nm and a bandwidth of ~70 nm, affording an 
axial resolution of ∼6.5 µm in air and ∼4.5 in tissue. Except for a short free-space optical 
path in the source arm of the system reserved for an optical isolator (EOT Isolator, 
Model: BB9-5I) to limit backreflections (which is undesirable for the SLD), the rest of 
the system is based on single-mode fibers (Puremode HI 1060, Corning) to reduce 
misalignment in future clinical studies.  The 50/50 coupler (Gould Fiber Optics) 
employed in the system is custom made to have ∼950 nm operating wavelength. The 
design of the four LCI arms (i.e., source arm, detection arm, sample arm, and reference 
arm) incorporates other miniature components (e.g., polarization control paddle, fiber- 
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optic collimator, and translation stage) to improve the portability of the system while 
controlling for the optical transmission loss. 
The interference fringes are detected by a custom-built, spectrometer-based 
detection system. The exiting beam from the detection arm fiber is collected by a lens to 
produce a collimated beam, which is then dispersed by a grating (Newport) to separate 
the polychromatic components.  These, in turn, are focused by another lens to a line on a 
linear CCD array detector or line-scan camera (Dalsa, Inc). The system is shown in 
Figure 9. The parameters of the grating, the lenses, and the optical path can be calculated 
from the spectrum of the light source, the numerical aperture of the fiber, the length of 
the linear array detector, the minimum ranging depth, and the size of the optical 
breadboard that accommodate the optical components. This line-scan camera is 
connected to the laptop computer by a PCMCIA data acquisition card that supports a 
camera-link interface (Imperx). The selected components for the detection system are 
listed in Table 1. 
 
Fiber
Lens 1
Lens 2
Grating
Linear array
detector Reflection
Dif
fra
ctio
n
 
Figure 9 Schematic of detection system of the LCI core. 
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Table 1 Specifications of main components of LCI core. 
Component Vendor Model Specifications 
Line-scan 
camera 
Dalsa 
(Waterloo, Ontario, 
Canada) 
P2-22 2K40 
2048 pixels, pixel size 10 µm, 
line rate 35,000 Hz 
Data acquisition 
board 
Imperx 
(Boca Raton, Florida, 
USA) 
VCE 
CLCB01 
Laptop card supporting 
camera-link interface 
Optical grating 
Newport 
(Rochester, NY, USA) 
10HG1100-
900-1 
1100 groves/mm, blaze angle 
32.7°, blaze wavelength 900 
nm, size 25 mm  × 25 mm 
Lens 1 
Thorlabs 
(Newton, New Jersey, 
USA) 
LB1471-A F = 50 mm, size 1″ 
Lens 2 Thorlabs LB1374-A F = 150 mm, size 2″ 
Optical 
breadboard 
Thorlabs MB1218 Size 18″ × 12″ 
 
3.1.2 LCI probe 
 
The LCI probe is custom-designed with a small diameter (0.5−0.7 mm) and 
long working distance (12−14 mm) to match the video otoscope optics. A GRIN lens 
with a diameter of 0.5 mm, length of about 3.5 mm, and working distance of 6 mm was 
initially used. The 8
º
 polish angles of the lens prevented large backreflections from 
surfaces of the probe. In order to achieve the long working distance, this lens was then 
polished and glued to the fiber (Figure 10(a)). The polished length of the lens and the 
glue layer thickness were calculated by theory and simulation in Prof. Stephen Boppart’s 
group [26]. The final probe had a long working distance in the range of 12−14 mm and 
spot size of 30 µm. Its focused beam profile is shown schematically in Figure 10(b).  
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Figure 10 Schematic (a) and beam demonstration (b) of the long working distance LCI probe.  
This fiber probe was interfaced to the video otoscope (Welch Allyn, Inc.) by 
being co-located within the ear speculum (plastic tip) of the otoscope. The solution for 
this interface was to use two different ear specula, one fixed ear speculum to mount the 
probe tip and a second disposable ear speculum for each imaging session (Figure 
11(left)). 
                    
Figure 11 Integration of LCI probe to otoscope head.   
 
3.1.3 Portable integrated system 
 
The integrated system is compact, portable, and convenient for use in outpatient 
clinic settings. In the portable cart, the 110 V to 240 V voltage converter (SYM 300DE, 
SIMRAN, India) (Figure 12(a-1)), the power generator (EP-1803, European Power 
Systems Ltd., Canada) (Figure 12(a-2)), and the SLD light source (Figure 12(a-3)) were 
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placed in the two upper drawers. The first breadboard for the reference arm and LCI core 
including the optical polarization paddles, the isolator, and the interferometer (Figure 
12(a-4)) and the second breadboard for the LCI detection system (Figure 12(a-5)) were 
placed in the two lower drawers. The laptop and the handheld otoscope were placed on 
the top of the cart for convenient usage. 
 
Figure 12 (a) Portable LCI otoscope system including (1) voltage converter, (2) power 
generator, (3) SLD source, (4) LCI core, (5) detection system, and (6) laptop and otoscope.   
(b) System software user interface with (1) otoscopy video, (2) LCI spectrum graph, and (3) 
LCI data graph. 
It takes about 30 seconds to 1 minute for each imaging session. The physician 
uses the system in a manner similar to a digital video otoscope. Video images on the 
software user interface enable the guidance of the LCI probe. While the 940 nm LCI 
beam is outside the range of human visual perception, the beam is visualized on the video 
by a bright spot because the silicon-based CCD cameras are sensitive up to nearly 1100 
nm. The functions of the program (such as data acquisition, review, storage, and analysis) 
are all designed to be user friendly.  
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An imaging session is started by the “Start Video” button. The working condition of the 
LCI otoscope is quickly checked by the clear video (Figure 12 (b-1)), conventional 
spectral shape in Spectrum plot (Figure 12 (b-2)), and a good SNR of LCI signal of skin 
or tape in the LCI data plot (Figure 12 (b-3)). The physician holds the otoscope and 
places the speculum of the otoscope into the ear canal. The otoscope can be carefully 
moved forward or backward to get the LCI beam in focus, which is indicated by the 
presence of a strong signal of the TM in the LCI data plot. The bright spot of the LCI 
beam in the video image shows the imaging position. The physician now pushes the 
“Start Acqusition” button to begin acquiring data, and then gently tilts the otoscope to 
different imaging positions. The imaging session is ended automatically at 30 seconds or 
by pushing the “Stop Acquisition” button. 
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3.2 SOFTWARE 
The software controlling the LCI system has been developed using the 
commercial programming tools of Labview and Matlab. The main graphical user 
interface (GUI) and the corresponding interfaces with various hardware drivers are 
implemented by Labview, while the data processing core is realized by integrating 
Labview and Matlab packages. There are three main components to the software: data 
acquisition, signal processing, and classification algorithm.   
3.2.1 Data acquisition 
 
The data acquisition component is able to acquire simultaneously the spectral 
data from the LCI spectrometer and the video signal from the otoscope.  This 
simultaneous acquisition will then permit correlation of the LCI depth-dependent signal 
with the spatial position of the beam on the tympanic membrane, as visualized in the 
video otoscope image. The linescan rate of 5,000 axial scans per second and pixel bit-
depth of 10 are being used to balance the desired SNR and signal processing rate for real-
time acquisition, processing, and display. 
3.2.2 Signal processing 
 
In the data processing component, the raw spectral data are processed by an 
algorithm (Figure 13) to correct dispersion and other optical aberrations, and are 
converted to the LCI axial scans, which describe the optical scattering information in 
depth [27]. 
The raw data are initially processed by subtracting the background noise. The 
background noise is computed by taking the average of 20 spectra when both the 
reference and sample arms are blocked. 
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Figure 13 Flowchart of data processing to correct dispersion.   
Due to dispersion and other aberrations, the fringes of the interference are not 
equally distributed in frequency across the line array. In order to correct this effect, the 
data is interpolated and then resampled. In order to have a correct reconstruction of the 
resampling, the data is upsampled before the interpolation to the Nyquist frequency, 
which is implemented by zero-padding in the time domain after converting the data by 
the fast Fourier transform. 
In Figure 14, the raw data and the processed data are shown. The upper plot 
represents the raw data from the camera with coarse fringes on the left and dense fringes 
on the right. The lower plot shows equally distributed fringes across the line array. 
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Figure 14 Raw data (top) and processed data (bottom) after dispersion correction.    
 
As a result, the dispersed signal in the raw axial scan (Figure 15(top)) is corrected in the 
processed axial scan (Figure 15(bottom)). Thicknesses of the pulse at intensity of 0.5 of 
the dispersed and processed signals are correspondingly 85 and 65 µm, respectively. The 
processed signal has narrowed 23.5% the dispersed s
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Figure 15 Axial scans before (top) and after (bottom) dispersion correction   
 
3.2.3 Classification algorithm 
 
All of the acquired LCI data serve as inputs to a classification algorithm and are 
processed to extract three parameters: thickness of the TM with or without a biofilm 
layer; intensity of optical backscatter; and optical attenuation through the TM, possible 
biofilm, and any effusion present within the middle ear. The thickness of the TM and 
biofilm layers is determined by the edge detection algorithm (Section 2.2). The intensity 
is the mean intensity of the layers over the entire depth scan. The attenuation is defined 
by the signal slope. These three parameters are then used for classification.  
First, thickness and intensity of each LCI axial scan were computed. The 
thickness was then initially analyzed to discard superfluous scans and detect the TM 
region. When collecting data, the probe may be directed to unwanted positions; for 
example, to the TM region over the malleus or to the edges of the ear canal, where the 
tissue is much thicker and not representative of the TM.  
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A normal TM is thinner in the central region and thicker along the periphery. 
Therefore, LCI data from the central region of normal TMs were detected and 
differentiated from other data, including data from the periphery of normal TMs and TMs 
with biofilms or effusion, by a hypothesis detection method based on the thickness and 
intensity parameters. The typical thickness of the normal TM is 20 µm for rat and 100 
µm for human. Biofilm layers increase this thickness by about 30 to 200 µm. 
In order to classify data from the periphery of normal TMs, from TMs with 
biofilm (early or well developed), and from TMs with effusion, a model classification 
was then applied. Representative signal models for the above cases were used. For each 
case, the signal model was determined by thickness, intensity, and attenuation, which 
were estimated from training data. From the training data, the mean thickness and 
intensity were computed first by Bayesian estimation [28-29]. Then these training data 
were normalized to their mean thickness and intensity, and attenuation was then 
estimated by the average attenuation of these normalized data.  
Next, a minimum distance classifier was implemented [28-29]. The input signal 
was matched with the models in term of the two features: thickness and intensity. Then 
the Euclidean distances of the input data with the signal models were calculated. The 
model that had minimum distance to the input data corresponded to the classified type of 
data (Figure 16). 
From the result of axial classification, data from normal TMs at both the central 
region and periphery were considered as normal axial scans. Other data types from TMs 
with biofilms or effusion were considered as abnormal axial scans. Percentages of normal 
and abnormal axial scans from the total acquired axial scans can be used to determine the 
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probability of a chronic infection with the presence of a biofilm and/or effusion. Further 
details about the thickness of TMs, type and thickness of biofilm, and effusion are also 
helpful for OM diagnosis.  
 
Figure 16 Flowchart of the classification algorithm.   
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CHAPTER 4 - ANIMAL STUDY 
 
4.1 RAT MODEL 
Demonstration of this LCI system and methodology was first implemented in a 
new rat OM model that was developed especially for this research. Under an IACUC-
approved protocol, Streptococcus pneumoniae biofilms were induced in Sprague-Dawley 
rats using a minimally invasive technique involving nasal cannula delivery and 
pressurization to deliver bacteria to the middle ear via the Eustachian tube. The rat has 
previously been widely used as a model for OM by introducing bacteria through a 
perforated TM or bulla.  While there have been many reported methods for inducing OM 
in models [30-31], only one recent report has described protocols for inducing middle ear 
biofilms in a chinchilla model [32].  
To induce middle ear biofilms, rats were inoculated biweekly and checked daily 
for OM development. Rats were first anesthetized using a subcutaneous injection of 
Carprofen (5 mg/kg) followed by an intraperitoneal injection of ketamine (100 mg/kg) 
and xylazine (10 mg/kg). A 30 µl volume of Streptococcus pneumoniae bacteria in a 
saline 1% methylcellulose solution at a concentration of 1 x 10
10
 CFU/ml was delivered 
into the left nasal cavity via a Teflon cannula. The rats were immediately transferred to a 
pressure chamber in which the air pressure was gradually raised to 50 kPa over 5 
minutes, held at 50 kPa for 5 minutes, and then gradually reduced back to atmospheric 
pressure over 5 minutes.  
Starting first with one group of five animals, four animals were used for 
inoculation and one served as a control. The inoculations were first administered once a 
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week. After five weeks without observing signs or symptoms of OM, the animal protocol 
was modified to allow bacterial inoculations biweekly instead of weekly, as originally 
planned. Since biofilms were expected to form after several recurrent OMs, and in order 
to increase the number of animals with OM, a second group of four rats was added to the 
study after three months.  
The increased chamber pressure drove the inoculation bolus into the middle ear, 
resulting in acute and chronic middle ear infections and growth of biofilms over a total 
period of seven months. At various time points, in vivo video otoscopy images and LCI 
data from the TMs of these animals were collected. Normal conditions, acute and chronic 
infections, and middle ear biofilms were observed. All of the TMs were dissected out for 
secondary ex vivo OCT imaging, and were subsequently fixed and embedded in paraffin 
for histological sectioning and comparative examination.  
4.2 RESULT 
 
During the seven-month animal study, eight animals were inoculated and one 
animal was maintained as a control. Noticeable differences were observed in the 
inoculated rat TMs using both video otoscopy images and LCI data, compared to the 
normal control animal. The differences were noticed despite the fact that most inoculated 
animals did not appear sick during the inoculation period. Tympanic membranes from all 
inoculated animals were monitored during every inoculation session. Otoscopy images 
and LCI data were acquired if any of the animals appeared sick or if abnormalities were 
found in TMs. Ex vivo OCT and histology images of TMs were also acquired if the rat 
had appeared severely infected on otoscopy and LCI.  
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The first acute OM was noticed by otoscopy from a rat in first group after seven 
weeks. The TM in this animal had darker and branching vessels and half of the TM 
appeared red and opaque.  Several acute OMs were recorded in three animals from both 
groups at later time points. However, these OMs resolved naturally in two to three days. 
Histology of the TM from one of the acute OM infections confirmed the presence of 
bacterial colonization behind the TM. The most interesting result was found in one 
animal in the second group. A severe infection was observed after four months of 
inoculations and following two recorded episodes of acute OM. The TM from this animal 
was dark red, prominent, and found to have two holes. Data from this middle ear acquired 
by LCI, OCT, and histology confirmed the severe infection and revealed the presence of 
additional biofilm structures behind the TM.   
Representative results from the animal study are described for a control and 
infected rat. The TM of the normal rat appeared translucent by video otoscopy (Figure 
17(a)) and the corresponding typical LCI signal showed a single, thin structure 
representing the thin TM (Figure 17(b)) 
 
(a)      (b)          
Figure 17 (a) Otoscope image and (b) typical LCI data from a normal rat TM.   
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This thin TM was also confirmed in the corresponding OCT images from this normal rat. 
Different positions of the OCT scans were implemented relative to the malleus (Figure 
18). The OCT images of the dissected TM (Figure 19) were acquired with the OCT beam 
incident on the inner surface of the TM, rather than on the external surface, in order to 
provide a full field of view. The narrow external ear canal of the rat prohibited OCT 
imaging across the full width of the TM from this orientation. Major portions of the TM 
were thin, while the periphery of the TM was noticeably thicker. Histology image of the 
normal rat also visualized the thin TM (Figure 20). 
 
Figure 18 Routine positions of OCT scans relative to the structures of the TM and the 
malleus. Four lateral scanning positions P1–P4 were implemented for each animal imaging 
session in order to acquire LCI data at various regions. 
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Figure 19 Ex vivo OCT images of a normal rat middle ear at four different positions (P1–
P4) across the malleus.  Positions correspond to labeled locations in Figure 18. 
 
Figure 20 Histological image of a normal rat middle ear. M = malleus; TM = tympanic 
membrane. 
In contrast, video otoscopy from the infected TM appeared cloudy, dark red, and 
with prominent hole-like regions (Figure 21(a)). The LCI signals from the infected rat 
TM exhibited additional scattering structures behind the TM. As an example, in the 
typical LCI scan, the additional structure appeared thick and lower scattering 
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immediately adjacent to the thin and higher-scattering TM. This structure was about 120 
µm thick, six times thicker than the TM from a normal rat (Figure 21(b)).  
 
 
Figure 21 (a) Otoscope image and (b) typical LCI data from the TM of an infected rat.  
In the ex vivo OCT images from the middle ear of the infected rat, additional 
structure after the TM was confirmed. The presence of the two prominent regions with 
holes filled by blood was also shown in the OCT images (Figure 22). These findings from 
the infected TM were visualized in the histological images as well. Even though some 
portions of the biofilm were not shown in the histological image (likely due to processing 
artifacts) as in the OCT images, the left portion of the biofilm (blue arrows), the two 
holes (red and blue squares), and bacteria colonization (Figure 23) were evident, which 
validated the presence of a bacterial biofilm as detected in the LCI data. 
 
              (a)                           (b) 
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Figure 22 Ex vivo OCT images of an infected rat middle ear at four different positions (P1–
P4) across the malleus.  Scan locations (P1–P4) are shown in Figure 18.  Note the increased 
thickness of the TM and biofilm structures. The prominent areas with holes filled by blood 
(as seen in Figure 21 (left)) are also recognized. 
 
 
Figure 23 Histological images of an infected rat middle ear (left) and bacterial colonization 
in middle ear (right).  Boxes show the holes and blue arrows indicate the biofilm structure 
behind the TM. 
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The in vivo video images of the rat TMs are out-of-focus because the very narrow 
ear canals prevented full insertion of the human otoscope ear speculum tip. To enable 
LCI data collection within the small rat ear canal, a bare LCI probe tip was inserted 
directly, and real-time LCI signals were used to monitor the position and placement 
relative to the TM, where in vivo LCI data was collected. By this method, 74 in vivo axial 
scans were successfully acquired. Despite this relatively limited number of LCI scans, 
these axial scans were sufficient to show the presence of additional scattering structures 
behind the TM, which were indicative of a biofilm. 
4.3 CLASSIFICATION OF RAT DATA 
Figure 24 reports the classification of the LCI data for ex vivo OCT data based on 
the thickness and intensity of the filtered axial scans.  There is clear separation between 
scans classified as normal from the normal rat (blue points) and those classified as 
infected from the infected rat (red points). Some data points from the infected rat data 
(left red points) fell within the normal area because they came from regions of the TM 
that did not have biofilms, as confirmed by histology. Similarly, some data points from 
normal TMs (right blue points) fell within the area classified as infected. These data 
points correspond to LCI scans acquired from regions over the malleus and along the 
edges of the TM, where natural thickening occurs.   
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Figure 24 Classification of LCI axial scans by thickness and intensity for ex vivo OCT data. 
Red circles = infected rat; blue circles = normal rat. 
  Based on the training data, six models of the rat LCI data were generated for 
normal TMs at thin (type 1) and thick regions (type 2 and 3) and TMs with effusion (type 
4) or early biofilm (type 5) and established biofilm (type 6) (Figure 25).  
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Figure 25 Signal models for rat TMs. 
The model classification was then applied to classify the filtered ex vivo LCI data 
into defined categories. In these filtered ex vivo LCI data, among 1786 axial scans from 
normal rats, 1561 scans were classified as normal types (1509 scans of type 1 and 52 
scans of type 2) and 225 axial scans were classified as abnormal types (26 scans of type 
4, 73 scans of type 5, and 126 scans of  type 6). The majority of scans from the normal 
rats are classified as a normal thin TM. 
  Among 1597 axial scans from infected rats, 167 axial scans were classified as 
normal types (100 scans of type 1 and 67 scans of type 2) and 1430 axial scans were 
classified as abnormal types (221 scans of type 4, 117 scans of type 5, and 1092 scans of  
type 6). The majority of scans from the infected rats are classified as a TM with an 
established biofilm.  
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The sensitivity and specificity of LCI with this classification algorithm for 
detecting the presence of a biofilm were 87% and 90%, respectively, using histological 
findings as the gold standard. 
Since the in vivo LCI data were acquired without video guidance, the sensitivity 
and specificity of in vivo LCI data classification were significantly lower (78% and 83%). 
Figure 26 indicates that a larger portion of data was acquired from periphery regions of 
the TMs in the normal rats and from the thin regions of the TM in the infected rat. These 
data increase the false positive and false negative cases and, hence, decrease the 
sensitivity and specificity. 
 
Figure 26 Classification of in vivo LCI data by thickness and intensity. Red circles = 
infected rat, blue cirles = normal rat. 
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CHAPTER 5 - DISCUSSION AND CONCLUSIONS 
 
Diagnosis of chronic OM is a challenge in middle ear pathology. Normally, 
chronic OM does not have signs that can be easily recognized by otoscopy, as can be 
done with acute OM. Three common methods have been used to diagnose chronic OM: 
standard otoscopy, pneumatic otoscopy and tympanometry. However, sensitivity and 
specificity of these methods are limited. Therefore, a combination of these methods for 
chronic OM diagnosis is currently used in order to achieve higher sensitivity and 
specificity. Beside diagnostic accuracy, quantitative characterization of infection is also 
limited in these available methods. In these circumstances, a new diagnostic tool for 
middle ear infection that overcomes the discussed limitations is highly motivated. This 
work has shown a novel diagnostic method for middle ear infection using an optical 
interferometry technique that is capable of detecting, quantifying, and monitoring middle 
ear biofilms non-invasively. A new animal biofilm model was also developed and used 
for validating this method. 
An enhanced otoscopy system has been constructed and demonstrated for 
collecting LCI and video otoscopy signals from a new rat middle ear biofilm model. This 
portable system has an LCI depth resolution of ~4.5 µm and an imaging depth range of 
~ 2 mm. It is appropriate for readily accessing the TM and detecting the presence of a 
biofilm on the inner surface of the TM, as well as the presence of any middle ear effusion 
(fluid). The observable differences between the LCI signals from normal and infected rat 
TMs demonstrate the capability and sensitivity for detecting middle ear biofilms. These 
new data offer the potential for more accurately classifying OM status. 
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Since the rat TM and middle ear structures are similar to those in the human ear 
(with human structures being larger in scale), the positive results from this pre-clinical 
animal study demonstrate the potential use of this enhanced otoscopy system for research 
and clinical use for the diagnosis, quantification, and monitoring of human OM. In the 
current system, axial scans are collected continuously in time and randomly in space, 
guided by both real-time video otoscopy and real-time LCI data collection. The collection 
of a large number of axial scans is sufficient to adequately sample the TM regions and 
classify the scans. Further miniaturization and use of micro-electro-mechanical-systems 
(MEMS)-based scanners would enable the rapid acquisition of 2-D and 3-D OCT images, 
but at increased equipment cost, equipment complexity, and computational processing 
and analysis time. 
In addition to the novelty of this enhanced otoscopy system and technique, this 
study represents the first demonstration of biofilm induction and growth by nostral 
inoculation and pressurization in rats. Typically, OM is induced via puncture of the TM, 
and only recently OM has been induced via nostril inoculation. At the time this rat model 
was developed for this study, there had been no such animal model for inducing and 
growing biofilms via nostril inoculation.  
Though our rat model was suitable for inducing OM and a biofilm, several 
challenges and limitations of this rat model were identified, especially for in vivo video 
otoscopy, LCI data collection, and OCT imaging. First, the immune system of these rats 
proved to be robust against OM. Though OM infections were frequently observed for one 
to two days after each inoculation, the infection appeared to be readily cleared, despite 
being regularly inoculated bi-weekly. Seven of eight inoculated rats did not show 
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biofilms despite a long inoculation period and recurrent infections. However, it should be 
noted that this pattern of infection and clearance is not completely unlike the process in 
humans, which is believed to lead to the formation of biofilms [9]. Second, the rat ear 
canal is very narrow, prompting the development of long working distance probes, and 
frequently out-of-focus video otoscopy images, resulting in limited video guidance to TM 
locations. Based on these study results, other animal models such as the chinchilla [26] 
will be investigated for future in vivo biofilm growth studies. 
The noted limitations of out-of-focus video otoscopy and reduced visual guidance 
of LCI beam placement experienced during this animal study are likely to be fully 
resolved during studies in humans. Since the standard otoscope and specula used in this 
study were designed for use in the human ear, which is much larger than the rat ear, even 
for pediatric patients, the LCI otoscope will have both video images and the LCI probe in 
focus. Real-time video otoscopy as well as the real-time LCI data acquisition will be used 
to guide the LCI probe beam to areas of interest across the TM. The real-time guidance 
will not only lead to the collection of an adequate quantity of axial scans but will also 
improve the efficiency of the classification by guiding the probe to acquire LCI data in 
the most suspicious areas that can be observed by the video. 
The classification algorithm developed during this research has proved to be 
highly effective at classifying LCI data from normal and infected TMs. The results of 
86% sensitivity and 90% specificity, compared to histological findings, are higher than 
those for diagnosing chronic OM using standard otoscopy (74% and 60%, respectively). 
Other currently available diagnostic methods such as pneumatic otoscopy and 
tympanometry can yield slightly higher sensitivities and specificities (70% to 90%) 
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compared to standard otoscopy, but these methods depend heavily on patient cooperation 
[7]. This classification algorithm is expected to achieve the same or better sensitivity and 
specificity for in vivo human LCI data, compared to what was achieved in this study for 
rat LCI data classification. Thousands of LCI axial-scan data will be used for 
classification from each scan session. Directing the LCI probe to the areas on the TM that  
are highly suspicious under otoscopy observations will also yield an expected 
improvement in sensitivity and specificity because fewer scans will be collected from 
regions that would not contain biofilms, such as over the malleus or from the epithelial 
tissue regions at the periphery of the TM. Since video otoscopy images are captured 
simultaneously with the LCI depth-scan data, and since the location of the LCI beam on 
the TM can be visualized on the video images, it is possible to use computer image 
processing methods to automatically determine which LCI scans were not from the TM, 
and discard this data prior to classification. 
OM is one of the two most common diseases in children. Detecting chronic OM 
and tracking antibiotic response are the major challenges of OM diagnosis and treatment. 
On the basis of the established correspondence between chronic OM and the presence of 
a bacterial biofilm in the middle ear, it appears feasible to diagnose chronic OM by non-
invasively detecting a bacterial biofilm in the middle ear and on the TM using LCI.  
To conclude, a portable enhanced otoscopy system demonstrates the application 
of LCI and OCT for OM diagnosis and the detection, classification, and quantification of 
middle ear biofilms. LCI signals with high axial resolution were selected to classify TMs 
and additional structures such as biofilms and effusions related to chronic OM. This 
research has been successfully demonstrated in a new middle ear biofilm animal model. 
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These results demonstrate the potential use of LCI and OCT for detecting and quantifying 
middle ear biofilms. This real-time data, assessment, and classification captured in an 
office-based clinical setting has the potential for assisting in the management of chronic 
OM. 
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